Sanofi India will commercially launch the first Indian-manufactured re-usable insulin pen, AllStar, in India, in October 2012.
Developed especially for patients in emerging markets, AllStar is meant for insulinized patients using Sanofi's insulin portfolio and also for diabetic patients who are starting to use insulin.
Sanofi global diabetes senior vice president Pierre Chancel said Sanofi has always been at the forefront of diabetes research and development.
"Sanofi India's manufacturing its own re-usable insulin device is the results of three years of exemplary team work with the sole purpose of offering a device that would match the needs of people with diabetes in India and other emerging markets," Chancel added.
AllStar is an easy-to-use device for patients and also supports physicians in early initiation of insulin therapy for better glycemic control and enhanced therapeutic outcomes, according to the company.
